Studies on the Effects of T Thyroxine, L-Carnitine and an L-Thyroxine-L

Studies on the Effects of T Thyroxine, L-Carnitine and an L-Thyroxine-L

003 1-3998/86/20 12- 1280$02.00/0 PEDIATRIC RESEARCH Vol. 20, No. 12, 1986 Copyright O 1986 International Pediatric Research Foundation, Inc. Printed in U.S. A. Studies on the Effects of t thyroxine, L-Carnitine and an L-Thyroxine-L-CarnitineCombination on Dipalmitoyl Phosphatidylcholine Content and on Phosphatidylcholine Species Composition in Fetal Rat Lungs ALFHRED LOHNINGER, HANS-PETER KRIEGLSTEINER, HEINRICH SALZER, WOLFGANG ERHARDT, WOLFGANG EPPL, AND ERICH KAISER Department of Medical Chemistry and First Department of Obstetrics and Gynecology, University of Vienna, Vienna, Austria, Department of Obstetrics and Gynecology, Malteser Clinic, Bonn, and Institute of Experimental Surgery, Technical University of Munich, Munich, Federal Republic of Germany ABSTRACT. The aim of the present study was to examine It is well established that glucocorticoids accelerate maturation the effects of maternal carnitine treatment combined with of the fetal lung in animals and decrease the incidence of respi- thyroxine, a hormone influencing both lung maturation and ratory distress syndrome in human infants. Since glucocorticoids carnitine metabolism. Administration of a carnitine-thy- are not completely effective in preventing respiratory distress roxine combination to pregnant rats resulted in a significant syndrome in human infants (1), there was current interest in the increase of DPPC content in fetal rat lungs to 8.8 f 1.8 use of other agents (2). Several studies have indicated that thyroid mg/g dry weight (mean f SD), compared with the control hormones have similar influences on lung differentiation (3, 4). group, the carnitine-treated group, and the thyroxine- Effects of glucocorticoids and thyroid hormones were more than treated group 15.4 +. 1.8 (p < 0.01), 5.6 f 1.5 (p < 0.01), additive (9,suggesting different mechanisms of actions. and 6.6 f 1.0 mg/g dry weight, respectively]. The portion We have shown that carnitine, like betamethasone, influenced of DPPC in the PC species increased significantly from the DPPC content in fetal rat lungs (6), likely via two dissimilar 20.9 f 2.1% in the control group and to 27.2 f 3.5% (p < mechanisms. In addition, we found that maternal administration 0.01) in the carnitine-thyroxine combination group. A sig- of a carnitine-betamethasone combination resulted in a signifi- nificant (p < 0.01) diminution of the palmitoyl-palmitoley1 cant increase in DPPC content of fetal rat lungs in comparison PC (16:0/16:1-PC) portion in the PC species was found. with untreated controls and with animals treated with carnitine Maternal carnitine administration resulted in an elevation or betamethasone alone (7). of the carnitine levels in the fetal lungs to approximately Carnitine, 3-hydroxy-4-trimethylaminobutyrate, is essential in twice those of the controls (p < 0.01). The combined lipid metabolism. The most important function of carnitine is adminstrration of carnitine and thyroxine resulted in no the transport of long chain fatty acids across the inner mitochon- increase in the total carnitine content but in a significant drial membrane (8). Thyroid hormone influences carnitine me- (p < 0.01) increase of the short chain acylcarnitine content. tabolism (9) and accelerates mitochondria1 fatty acid oxidation The present results demonstrate that carnitine potentiates by effects on carnitine palmitoyltransferase (10). the effects of thyroxine on DPPC content and support the The aim of the present study was to examine the effects of concept of an interrelationship between carnitine and thy- maternal carnitine treatment combined with thyroxine, a hor- roxine metabolism. (Pediatr Res 20: 1280-1283, 1986) mone influencing both lung maturation and carnitine metabo- lism. The amount of surfactant stored in alveolar type I1 cells is Abbreviations crucial for the survival of premature babies. DPPC is the prin- PC, phosphatidylcholine cipal component of the lung surfactant complex and is mainly PC 30,30 carbon atoms in acyl radicals responsible for its surface active properties (2). Thus to evaluate PC 32,32 carbon atoms in acyl radicals the effects of the different maternal treatments we determined PC 34,34 carbon atoms in acyl radicals both DPPC content and the portion of DPPC in total PC in fetal PC 36,36 carbon atoms in acyl radicals rat lungs. PC 38,38 carbon atoms in acyl radicals 16:0/16:1 PC, palmitoyl-palmitoley1 PC MATERIALS AND METHODS 16:1/16:0 PC, palmitoleyl-palmitoy1 PC DPPC, dipalmitoyl PC Ninety-six female Wistar rats of stock Ch bb-Thom with an average weight of 300 g and an expected gestation period of 23 days were randomized and divided into eight groups, four groups Received February 6. 1986: accepted July 22, 1986. reported here, four groups reported elsewhere (7). The gestational Reprint requests Alfred Lohninger, Institute for Medical Chemistry, University age was known within 24 h. The rats were treated intraperito- of Vienna. Wahringerstrasse 10. A-I090 Vienna, Austria. neally from day 16 to day 19 of gestation according to the This work was supported by grants from the Medical Scientific Foundation of the Mayor of Vienna. Austria, and by grants from the Allianz Insurance Company, schedule shown in Table 1. FRG. Preparation of lung tissue. Immediately after delivery of the 280 CARNITINE, T4-EFFECTS ON FETAL LUNG DPPC 1281 fetuses on gestational day 20 by caesarean section, the fetal The portion of DPPC in the PC species in the fetal rat lungs trachea was clamped before spontaneous inspiration could occur. exhibited a significant rise (p < 0.01) in the thyroxine-carnitine The chests of the fetuses were opened by means of parasternal combination group. Only a moderate increase after maternal incision. The fetal lungs were then grouped according to litter to thyroxine or carnitine treatment was noted (Table 2). preclude station-related differences. The fetal lungs were homog- PC 32 monoenic species. The PC 32 monoenic species can be enized, extracted, and washed using the method of Folch el al. characterized as palmitoyl-palmitoley1 PC ( 16:0/ 16: 1 PC) and (1 1). palmitoleyl-palmitoy1 PC (16: 1/16:0 PC) (6). Phospholipid analysis. The main phospholipid classes were The portion of palmitoyl-palmitoleyl PC in total PC decreased separated as bands by thin-layer chromatography using the sol- significantly (p < 0.01) after the combined administration of vent system chloroform/methanol/l% potassium chloride solu- thyroxine and carnitine in comparison with the control value. tion (4314714, v/v/v) (6). 1,2 Dipalmitoyl-sn-glycero-3-phospho- This decrease was less pronounced after administration of car- choline and the glycero-3-phosphocholine species composition nitine or thyroxine alone (Table 2). were assayed as the corresponding diacylglycerol trimethylsily- After thyroxine treatment a significant increase (p < 0.01) of lether derivatives by gas-liquid chromatography with glass cap- the palmitoleyl-palmitoy1 PC portion in total PC was found illary columns (12). compared with the control group. This increase was less pro- Carnitine assay. The tissue was flash-frozen immediately after nounced after the combined administration of carnitine and removal. The perchloric acid extracts were used for assaying free thyroxine. and short chain acylcarnitine. The carnitine esters were saponi- Phosphatidylcholine species composition. In most methods fied and assayed as free carnitine by radioenzymatic means (13), commonly used for determination of surfactant PC, disaturated with two modifications: HEPES instead of TRIS buffer (14) and PC consisting of DPPC and palmitoyl-myristoyl PC is deter- N-ethyl-maleimide instead of tetrathionate (15). mined. Chemicals. "L-Carnitin-Leopold" was obtained from Leopold Both maternal carnitine and thyroxine treatment failed to Ltd. (Graz, Austria). Chloroform, methanol, pyridine, hexame- increase the portion of palmitoyl-myristoyl PC in total PC (Table thyldisilazane, thin-layer chromatography plates (silica gel 60), 3). But there is a pronounced increase of the PC 32 portion in and HEPES were obtained from E. Merck (Darmstadt, FRG). total PC, obviously an additive effect of the increase of the two Bacillus cereus-derived phospholipase C and carnitine acetyl- PC 32 species, DPPC and palmitoleyl-palmitoy1 PC (Table 2). transferase were obtained from Boehringer-Mannheim (Mann- Also, maternal administration of the carnitine-thyroxine com- heim, FRG). Labeled acetyl coenzyme A was obtained from New bination resulted in a significant (p < 0.01) increase of the PC England Nuclear (Boston, MA). N-Ethylmaleimide and dimyris- 32 portion in total PC (Table 3). This time, however, the PC 32 toyl-sn-glycero-3-phosphocholine were supplied by Sigma Chem- increase is due mainly to the significant (p < 0.01) increase of ical Co. (St. Louis, MO). the DPPC portion. Statistical comparisons between the different groups were Generally, the increase of the PC 32 portion in the treated made using analysis of variance followed by Dunnet's t test for groups was mainly compensated by a decrease of the PC 34 multiple comparison (16). portion in the PC species (Table 3). Carnitine. Figure 1 shows the content of total carnitine and RESULTS short chain acylcarnitine in the fetal lungs. Maternal carnitine Only small differences of the total phospholipid content in the administration (20 mglkg) caused a significant increase (p < fetal rat lungs were found in the different treatment groups (data 0.01) in the total carnitine content and short chain acylcarnitine not shown). content. Thyroxine failed to influence the carnitine content. DPPC. The combined administration of thyroxine and carni- Unexpectedly, the combined administration of carnitine and tine resulted in a marked increase in the DPPC content in thyroxine resulted in no increase of total carnitine content but comparison with the control group (p < 0.01), the carnitine- in a striking increase (p < 0.01) of short chain acylcarnitine treated group (p < 0.01), and the thyroxine-treated group. A content in the fetal lungs. Obviously, the sole increase of short moderate response was noted after thyroxine, and no response chain acylcarnitine is specific for the combination.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us